PGI2 ADVERSE EVENTS OF PROMETHAZINE AND ONDANSETRON IN YOUNG CHILDREN AND WOMEN OF CHILD-BEARING AGE: A PHARMACOVIGILANCE STUDY BASED ON THE FDA ADVERSE EVENT REPORTING SYSTEM

@article{Seddoh2010PGI2AE,
  title={PGI2 ADVERSE EVENTS OF PROMETHAZINE AND ONDANSETRON IN YOUNG CHILDREN AND WOMEN OF CHILD-BEARING AGE: A PHARMACOVIGILANCE STUDY BASED ON THE FDA ADVERSE EVENT REPORTING SYSTEM},
  author={Sa Seddoh and J. J. Guo and Fo Ajayi and Patricia Wigle},
  journal={Value in Health},
  year={2010},
  volume={13}
}
  • Sa Seddoh, J. J. Guo, +1 author Patricia Wigle
  • Published 2010
  • Medicine
  • Value in Health
  • s A69 the warfarin and $10,195 (12,780) in the warfarin and NSAID groups (p < 0.01). CONCLUSIONS: This analysis did not identify a difference in the odds of having a GI bleed when on warfarin or warfarin plus NSAIDS. Unexpectedly, there were significantly lower costs for the warfarin plus NSAIDs group. These results should be interpreted with caution due to the small sample size and limitations of retrospective analysis. PGI2 ADVERSE EVENTS OF PROMETHAZINE AND ONDANSETRON IN YOUNG CHILDREN AND… CONTINUE READING